Statistics in Medicine
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Effect of dependent errors in the assessment of diagnostic or screening test accuracy when the reference standard is imperfect
2012
-
Statistical issues in the design and analysis of expertise‐based randomized clinical trials
2008
-
Meta‐analysis of screening data: a survey of the literature
1999
-
Variation in baseline risk as an explanation of heterogeneity in meta‐analysis
1997
-
Discission: Nancy Geller and M Stylianou, practical issues in data monitoring of clinical trials: Summary of responses to a questionnaire at NIH
1993
-
Discussion: Frank W Rockhold and G Enas, data monitoring and interim analyses in the pharmaceutical industry: Ethical and logistical considerations: George W Williams et al, monitoring of clinical trials and interim analyses from a drug sponsor's point of view
1993
-
Discussion: Stephen George, a survey of monitoring practices in cancer clinical trials: Stephanie Green and John Crowley, data monitoring committees for Southwest Oncology Group clinical trials
1993
-
A flexible model based on piecewise linear approximation for the analysis of left truncated right censored data with covariates, and applications to Worcester Heart Attack Study data and Channing House data.
43:233-255.
2024
-
Two‐stage targeted maximum likelihood estimation for mixed aggregate and individual participant data analysis with an application to multidrug resistant tuberculosis.
43:342-357.
2024
-
Estimation of standard deviations and inverse‐variance weights from an observed range.
41:242-257.
2022
-
Estimation of diagnostic test accuracy: A “Rule of Three” for data with repeated observations but without a gold standard.
40:4815-4829.
2021
-
Meta‐analysis of quantile intervals from different studies with an application to a pulmonary tuberculosis data.
39:4519-4537.
2020
-
Correction to Walter SD, Turner RM, Macaskill P. Optimising the two‐stage randomised trial design when some participants are indifferent in their treatment preferences (2019). Statistics in Medicine 38, 2317‐2331.
39:1591-1591.
2020
-
Randomised trials with provision for early stopping for benefit (or harm): The impact on the estimated treatment effect.
38:2524-2543.
2019
-
Optimising the two‐stage randomised trial design when some participants are indifferent in their treatment preferences.
38:2317-2331.
2019
-
Methods to improve the estimation of time‐to‐event outcomes when data is de‐identified.
38:625-635.
2019
-
Incorporation of frailties into a cure rate regression model and its diagnostics and application to melanoma data.
37:4421-4440.
2018
-
Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
36:1506-1518.
2017
-
Knowledge translation in biostatistics: a survey of current practices, preferences, and barriers to the dissemination and uptake of new statistical methods.
35:805-818.
2016
-
Inference on cancer screening exam accuracy using population‐level administrative data.
35:130-146.
2016
-
The Africa Center for Biostatistical Excellence: a proposal for enhancing biostatistics capacity for sub‐Saharan Africa.
34:3481-3489.
2015
-
Value of information methods for assessing a new diagnostic test.
33:1801-1815.
2014
-
Ratio of geometric means to analyze continuous outcomes in meta‐analysis: comparison to mean differences and ratio of arithmetic means using empiric data and simulation.
31:1857-1886.
2012
-
Optimal allocation of participants for the estimation of selection, preference and treatment effects in the two‐stage randomised trial design.
31:1307-1322.
2012
-
Testing the evolution process of prostate‐specific antigen in early stage prostate cancer: what is the proper underlying model?.
30:3038-3049.
2011
-
Bayesian methods for meta‐analysis of causal relationships estimated using genetic instrumental variables.
29:1298-1311.
2010
-
Analysis of the relationship between longitudinal gene expressions and ordered categorical event data.
28:2817-2832.
2009
-
A geometric confidence ellipse approach to the estimation of the ratio of two variables. Statistics in Medicine 2008; 27:5956–5974..
28:2723-2723.
2009
-
A geometric confidence ellipse approach to the estimation of the ratio of two variables.
27:5956-5974.
2008
-
Analysis of a nonsusceptible fraction with current status data.
27:2715-2730.
2008
-
Author's Reply.
27:2734-2735.
2008
-
Use of instrumental variables in the analysis of generalized linear models in the presence of unmeasured confounding with applications to epidemiological research.
27:1539-1556.
2008
-
Effect of exposure misclassification on the mean squared error of population attributable risk and prevented fraction estimates.
26:4833-4842.
2007
-
Statistical evidence in medical trials: What do the data really tell us? Stephen D. Simon, Oxford University Press, Oxford, 2006. No. of pages: xvii + 197. Price: £65.00, $114.50 hardcover; £25.00, $44.50 paperback. ISBN 0‐19‐856760‐X (hardcover), ISBN 0‐19‐856761‐8 (paperback).
26:3825-3826.
2007
-
Semi‐parametric regression models for cost‐effectiveness analysis: improving the efficiency of estimation from censored data.
26:3274-3299.
2007
-
Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: A Monte Carlo study (p n/a) by Peter C. Austin, Paul Grootendorst, Sharon‐Lise T. Normand, Geoffrey M. Anderson, Statistics in Medicine, Published Online: 16 June 2006. DOI: 10.1002/sim.2618.
26:3208-3210.
2007
-
A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study.
26:734-753.
2007
-
Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study.
26:754-768.
2007
-
Generalized gamma frailty model.
25:2797-2816.
2006
-
Correction.
25:720-720.
2006
-
Cost-effectiveness analysis for multinational clinical trials.
24:1965-1982.
2005
-
The partial area under the summary ROC curve.
24:2025-2040.
2005
-
The value of information and optimal clinical trial design.
24:1791-1806.
2005
-
1. Dicing with death: chance, risk and health. Stephen Senn, Cambridge University Press, Cambridge, 2003. No of pages: xii+251. Price:£14.99, $28.00 (paperback). ISBN: 0-521-54023-2.
24:1453-1453.
2005
-
Regression methods for cost-effectiveness analysis with censored data.
24:131-145.
2005
-
Two‐sample scale tests for comparison of metabolic rates for styrene in previously exposed and unexposed groups.
23:591-599.
2004
-
Incremental net benefit in randomized clinical trials with quality‐adjusted survival.
22:353-362.
2003
-
Improved up‐and‐down designs for phase I trials.
22:69-82.
2003
-
Clinical research and trials in developing countries.
21:2859-2867.
2002
-
Assessing the gain in diagnostic performance when combining two diagnostic tests.
21:2527-2546.
2002
-
A comparison of methods to detect publication bias in meta‐analysis by P. Macaskill, S. D. Walter and L. Irwig, Statistics in Medicine, 2001; 20:641–654.
21:1803-1803.
2002
-
Authors' Reply.
21:1804-1804.
2002
-
Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data.
21:1237-1256.
2002
-
Preface.
21:327-329.
2002
-
Bruno de Finetti: the mathematician, the statistician, the economist, the forerunner.
20:3651-3666.
2001
-
Number needed to treat (NNT): estimation of a measure of clinical benefit.
20:3947-3962.
2001
-
Cost‐effectiveness analysis when the WTA is greater than the WTP.
20:3251-3259.
2001
-
Incremental net benefit in randomized clinical trials.
20:1563-1574.
2001
-
Estimating the number needed to treat (NNT) index when the data are subject to error.
20:893-906.
2001
-
A comparison of methods to detect publication bias in meta‐analysis.
20:641-654.
2001
-
Methodological issues in the development of theCanadian Cancer Incidence Atlas.
19:2437-2449.
2000
-
Using an antedependence test to analyse post-operative pain measurements.
19:1889-1899.
2000
-
Meta-analysis of screening data: a survey of the literature.
18:3409-3424.
1999
-
Author's reply.
18:237-238.
1999
-
Variation in baseline risk as an explanation of heterogeneity in meta-analysis - by S. D. Walter, Statistics in Medicine, 16, 2883-2900 (1997) - Author's reply.
18:237-238.
1999
-
Variation in baseline risk as an explanation of heterogeneity in meta-analysis by S. D. Walter,Statistics in Medicine,16, 2883-2900 (1997).
18:233-237.
1999
-
Bias in the evaluation of DNA-amplification tests for detecting Chlamydia trachomatis..
17:1064-1066.
1998
-
Bias in the evaluation of DNA-amplification tests for detectingChlamydia trachomatis by A. Hadgu,Statistics in Medicine,16, 1391-1399 (1997).
17:1064-1065.
1998
-
Sample size and optimal designs for reliability studies.
17:101-110.
1998
-
Sample size and optimal designs for reliability studies.
17:101-110.
1998
-
Variation in baseline risk as an explanation of heterogeneity in meta-analysis.
16:2883-2900.
1997
-
Effects of dependent errors in the assessment of diagnostic test performance.
16:2157-2175.
1997
-
A simple test for spatial pattern in regional health data (vol 13, pg 1037, 1994).
15:335-335.
1996
-
CORRECTIONS: A SIMPLE TEST FOR SPATIAL PATTERN IN REGIONAL HEALTH DATA.
15:335-335.
1996
-
A simple test for spatial pattern in regional health data.
14:1393-1394.
1995
-
A simple test for spatial pattern in regional health data.
13:1037-1044.
1994
-
Assessing spatial patterns in disease rates.
12:1885-1894.
1993
-
Visual and statistical assessment of spatial clustering in mapped data.
12:1275-1291.
1993
-
On population and individual bioequivalence.
12:1109-1124.
1993
-
A SURVEY OF MONITORING PRACTICES IN CANCER CLINICAL-TRIALS - DATA MONITORING COMMITTEES FOR SOUTHWEST ONCOLOGY GROUP CLINICAL-TRIALS - DISCUSSION.
12:457-459.
1993
-
PRACTICAL ISSUES IN DATA MONITORING OF CLINICAL-TRIALS - SUMMARY OF RESPONSES TO A QUESTIONNAIRE AT NIH - DISCUSSION.
12:553-553.
1993
-
Preface.
12:415-415.
1993
-
Comparing in‐patient classification systems: A problem of non‐nested regression models.
11:1321-1331.
1992
-
CTS: A clinical trials simulator.
9:787-801.
1990
-
Cost and efficiency in clinical trials: Preface.
9:1.
1990
-
Preface.
9:1-1.
1990
-
Selection of patients for randomized controlled trials: Implications of wide or narrow eligibility criteria.
9:73-86.
1990
-
The effect of non‐differential exposure misclassification on estimates of the attributable and prevented fraction.
7:1073-1085.
1988
-
Evaluating the survival of cancer cases detected by screening.
6:885-900.
1987
-
Obtaining medically meaningful answers from an overview of randomized clinical trials.
6:281-286.
1987
-
Preface.
6:217-218.
1987
-
Cause‐deleted proportional mortality analysis and the healthy worker effect.
5:61-71.
1986
-
A note on optimal sampling for the comparison of proportions or rates.
4:541-542.
1985
-
Small sample estimation of log odds ratios from logistic regression and fourfold tables.
4:437-444.
1985
-
Why do we need some large, simple randomized trials?.
3:409-420.
1984
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)